Literature DB >> 17400657

Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke.

Chung-Wah Siu1, Man-Hong Jim, Hee-Hwa Ho, Raymond Miu, Stephen W L Lee, Chu-Pak Lau, Hung-Fat Tse.   

Abstract

BACKGROUND: Atrial fibrillation (AF) that occurs as a frequent complication of myocardial infarction (MI) is associated with a poor clinical outcome. It nonetheless remains uncertain whether AF that occurs transiently during MI is associated with a subsequent increased risk of the development of AF and ischemic stroke.
METHODS: We retrospectively studied the impact of transient AF on the long-term risk of the occurrence of AF, ischemic stroke, and mortality in 431 consecutive patients (mean [+/- SEM] age, 64 +/- 1 years; 75% men). All patients had experienced an acute inferior ST-segment-elevation MI and had preserved left ventricular ejection fraction (LVEF) [> 45%].
RESULTS: All patients were in sinus rhythm on hospital admission, and transient AF was observed in 59 patients (13.7%) during their hospitalization for MI. On hospital discharge, all patients were in sinus rhythm and had been prescribed antiplatelet agents alone as antithrombotic therapy. Patients in whom transient AF developed during MI were older (mean age, 70 +/- 1.4 vs 64 +/- 0.7 years, respectively; p < 0.01) and more likely to be women (37% vs 23%, respectively; p < 0.02) compared with those without AF. At 1-year follow-up, the incidence of AF (22.0% vs 1.3%, respectively; p < 0.01) and ischemic stroke (10.2% vs 1.8%, respectively; p < 0.01) was higher in patients with transient AF than in those without transient AF. The total mortality rate was nonetheless similar (5.6% vs 6.8%, respectively; p = 0.73); Cox regression analysis demonstrated that age > 65 years and transient AF during MI were independent predictors of the subsequent occurrence of AF and the development of ischemic stroke.
CONCLUSION: Transient AF complicating acute inferior MI is associated with an increased future risk of AF occurrence and ischemic stroke in patients with preserved LVEF, despite the use of antiplatelet therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400657     DOI: 10.1378/chest.06-2733

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies.

Authors:  Yan-Guang Li; Marco Borgi; Gregory Yh Lip
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2018-10-24

2.  Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials.

Authors:  Andrew B Hughey; Xiaokui Gu; Brian Haymart; Eva Kline-Rogers; Steve Almany; Jay Kozlowski; Dennis Besley; Gregory D Krol; Syed Ahsan; Scott Kaatz; James B Froehlich; Geoffrey D Barnes
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

Review 3.  Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.

Authors:  Shadi Yaghi; Hooman Kamel
Journal:  Stroke       Date:  2017-09-15       Impact factor: 7.914

4.  Long-term outcome and prognostic factors after spontaneous cerebellar hemorrhage.

Authors:  Vincent Pong; Koon-Ho Chan; Boon-Hor Chong; Wai-Man Lui; Gilberto Ka-Kit Leung; Hung-Fat Tse; Jenny Kan-Suen Pu; Chung-Wah Siu
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

Review 5.  Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Marta Garofoli; Elisa Ramundo; Cristina Poltronieri; Giovanni Mazzotta; Giuseppe Ambrosio; Paolo Verdecchia
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

6.  The significance of new onset atrial fibrillation complicating acute myocardial infarction.

Authors:  Oren Zusman; Guy Amit; Harel Gilutz; Doron Zahger
Journal:  Clin Res Cardiol       Date:  2011-09-11       Impact factor: 5.460

Review 7.  Atrial Fibrillation Complicating Acute Coronary Syndromes.

Authors:  Sean D Pokorney; Meena Rao; Kent R Nilsson; Jonathan P Piccini
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 8.  Mortality Risk Associated with AF in Myocardial Infarction Patients.

Authors:  Rajiv Sankaranarayanan
Journal:  J Atr Fibrillation       Date:  2012-10-06

9.  The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.

Authors:  Ming-Liang Zuo; Shasha Liu; Koon-Ho Chan; Kui-Kai Lau; Boon-Hor Chong; Kwok-Fai Lam; Yap-Hang Chan; Yuk-Fai Lau; Gregory Y H Lip; Chu-Pak Lau; Hung-Fat Tse; Chung-Wah Siu
Journal:  J Interv Card Electrophysiol       Date:  2013-02-07       Impact factor: 1.900

10.  Atrial fibrillation in myocardial infarction patients: Impact on health care utilization.

Authors:  Alanna M Chamberlain; Suzette J Bielinski; Susan A Weston; Winslow Klaskala; Roger M Mills; Bernard J Gersh; Alvaro Alonso; Véronique L Roger
Journal:  Am Heart J       Date:  2013-08-17       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.